These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 35275947)

  • 21. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-Term Prediction of Adverse Outcomes Using the sFlt-1 (Soluble fms-Like Tyrosine Kinase 1)/PlGF (Placental Growth Factor) Ratio in Asian Women With Suspected Preeclampsia.
    Bian X; Biswas A; Huang X; Lee KJ; Li TK; Masuyama H; Ohkuchi A; Park JS; Saito S; Tan KH; Yamamoto T; Dietl A; Grill S; Verhagen-Kamerbeek WDJ; Shim JY; Hund M
    Hypertension; 2019 Jul; 74(1):164-172. PubMed ID: 31188674
    [TBL] [Abstract][Full Text] [Related]  

  • 23. sFlt-1/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain).
    Perales A; Delgado JL; de la Calle M; García-Hernández JA; Escudero AI; Campillos JM; Sarabia MD; Laíz B; Duque M; Navarro M; Calmarza P; Hund M; Álvarez FV;
    Ultrasound Obstet Gynecol; 2017 Sep; 50(3):373-382. PubMed ID: 27883242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble fms-like tyrosine kinase 1 and placental growth factor ratio for predicting preeclampsia in elderly gravida.
    Phupong V; Areeruk W; Tantbirojn P; Lertkhachonsuk R
    Hypertens Pregnancy; 2020 May; 39(2):139-144. PubMed ID: 32202171
    [No Abstract]   [Full Text] [Related]  

  • 25. Prediction of adverse perinatal outcome by serum placental growth factor and soluble fms-like tyrosine kinase-1 in women undergoing induction of labor.
    Fiolna M; Machuca M; Karampitsakos T; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Nov; 54(5):604-608. PubMed ID: 31444934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
    Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
    Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
    Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
    Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of the sFlt-1/PlGF ratio for preeclampsia in twin pregnancies: a retrospective study.
    Shinohara S; Sunami R; Kasai M; Yasuda G; Uchida Y
    Hypertens Pregnancy; 2021 Nov; 40(4):330-335. PubMed ID: 34697976
    [No Abstract]   [Full Text] [Related]  

  • 29. Short-term prediction of preeclampsia using the sFlt-1/PlGF ratio: a subanalysis of pregnant Japanese women from the PROGNOSIS Asia study.
    Ohkuchi A; Saito S; Yamamoto T; Minakami H; Masuyama H; Kumasawa K; Yoshimatsu J; Nagamatsu T; Dietl A; Grill S; Hund M
    Hypertens Res; 2021 Jul; 44(7):813-821. PubMed ID: 33727707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between placenta-associated circulating biomarkers and composite adverse delivery outcome of a likely placental cause in healthy post-date pregnancies.
    Bowe S; Mitlid-Mork B; Georgieva A; Gran JM; Redman CWG; Staff AC; Sugulle M
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1893-1901. PubMed ID: 34212381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of adverse perinatal outcome and the mean time until delivery in twin pregnancies with suspected pre-eclampsia using sFlt-1/PIGF ratio.
    Karge A; Seiler A; Flechsenhar S; Haller B; Ortiz JU; Lobmaier SM; Axt-Fliedner R; Enzensberger C; Abel K; Kuschel B; Graupner O
    Pregnancy Hypertens; 2021 Jun; 24():37-43. PubMed ID: 33647841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
    Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
    Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does a sFlt-1/PlGF ratio result > 655 before 34 weeks' gestation necessitate preterm delivery within 2 days? A retrospective observational study.
    Siepen C; Brennecke S
    J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2371047. PubMed ID: 38926094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The sFLT-1/PlGF Ratio for the Prediction of Preeclampsia-Related Adverse Fetal and Maternal Outcomes in Women with Preexisting Diabetes.
    Provendier A; Migliorelli F; Loussert L; Boileau BG; Vayssiere C; Hamdi SM; Hanaire H; Dupuis N; Guerby P
    Reprod Sci; 2024 Aug; 31(8):2371-2378. PubMed ID: 38605263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenic factors during pregnancy in Asian women with elevated blood pressure in early pregnancy and the risk of preeclampsia: a longitudinal cohort study.
    Zhu J; Zhang J; Ng MJ; Chern B; Yeo GS; Tan KH
    BMJ Open; 2019 Dec; 9(11):e032237. PubMed ID: 31791965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia: A Systematic Review and Meta-analysis.
    Lim S; Li W; Kemper J; Nguyen A; Mol BW; Reddy M
    Obstet Gynecol; 2021 Jan; 137(1):72-81. PubMed ID: 33278298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Prognostic Value of the sFlt-1/PlGF Ratio in Early-Onset Preeclampsia.
    Tasta O; Parant O; Hamdi SM; Allouche M; Vayssiere C; Guerby P
    Am J Perinatol; 2021 Aug; 38(S 01):e292-e298. PubMed ID: 32446261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
    Palmrich P; Kalafat E; Pateisky P; Schirwani-Hartl N; Haberl C; Herrmann C; Khalil A; Binder J
    Ultrasound Obstet Gynecol; 2024 May; 63(5):619-626. PubMed ID: 37774098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
    Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dilba P; Schoedl M; Hund M; Verlohren S
    N Engl J Med; 2016 Jan; 374(1):13-22. PubMed ID: 26735990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort.
    Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT
    Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.